D. Parkin

发表

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

G. Bonsel, C. Gudex, P. Kind, 2011, Quality of Life Research.

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Relationship between service ecology, special observation and self-harm during acute in-patient care: City-128 study

K. Bhui, S. Curtis, A. Simpson, 2008, British Journal of Psychiatry.

Is the aim of the English health care system to maximize QALYs?

N. Devlin, D. Parkin, J. Sussex, 2012, Journal of health services research & policy.

The Influence of Cost-Effectiveness and Other Factors on NICE Decisions

N. Devlin, N. Rice, D. Parkin, 2010, Health economics.

The design and analysis of a randomized controlled trial to evaluate computerized decision support in primary care: the COGENT study.

J. Grimshaw, M. Eccles, E. McColl, 2000, Family practice.

Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices

J. Brazier, A. Tsuchiya, D. Parkin, 2002 .

Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial

David Parkin, Nick Steen, Martin Eccles, 2002, BMJ : British Medical Journal.

Equity and efficiency in public health: The contribution of health economics

S. Morris, N. Devlin, D. Parkin, 2010 .

Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data.

David Parkin, John Browne, Nancy J Devlin, 2010, Health economics.

Using the EQ-5D as a performance measurement tool in the NHS

David Parkin, Nancy Devlin, John Browne, 2009 .

Statistical Analysis of EQ-5D Profiles: Does the Use of Value Sets Bias Inference?

Nigel Rice, David Parkin, Nancy Devlin, 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

Measuring production efficiency of acute hospitals in Scotland, 1991-94: validity issues in data envelopment analysis

David Parkin, Bruce Hollingsworth, B. Hollingsworth, 1997 .

New Methods for Analysing the Distribution of EQ-5D Observations

David Parkin, Yan Feng, Nancy Devlin, 2018 .

Methods for Analysing and Reporting EQ-5D Data

N. Devlin, D. Parkin, B. Janssen, 2020 .

Analysis of EQ-5D Values

N. Devlin, D. Parkin, B. Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

C. Cleeland, S. Ikeda, M. Herdman, 2017, Quality of Life Research.

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.

G. Illei, A. Steinberg, D. Parkin, 2002, Arthritis and rheumatism.

Is the Aim of the Health Care System to Maximise QALYs? An Investigation of ‘What Else Matters’ in the NHS

N. Devlin, J. Appleby, D. Parkin, 2011 .

QA4 IS THE AIM OF THE HEALTH CARE SYSTEM TO MAXIMISE QALYS? AN INVESTIGATION OF ‘WHAT ELSE MATTERS’ IN THE NHS

N. Devlin, D. Parkin, J. Sussex, 2011 .

Longitudinal study of patients’ health-related quality of life using EQ-5D-3L in 11 Swedish National Quality Registers

N. Devlin, D. Parkin, O. Rolfson, 2022, BMJ Open.

Patient charges and the demand for dental care in Scotland, 1962–81

D. Parkin, B. Yule, 1988 .

Computed tomography in dementia: an expensive innovation?

A. Ludbrook, D. Parkin, 1983 .

Variations in Health-Related Quality of Life (HRQoL) and survival 1 year after stroke: five European population-based registers

C. McKevitt, C. Wolfe, S. Ayis, 2015, BMJ Open.

An economic analysis of human milk supplementation for very low birth weight babies in the USA

A. Lucas, D. Parkin, G. Hampson, 2019, BMC Pediatrics.

Analysis of EQ VAS Data

David Parkin, Nancy Devlin, Bas Janssen, 2020 .

What Determines the Shape of an EQ-5D Index Distribution?

N. Devlin, D. Parkin, Yan Feng, 2014 .

An evaluation of computerised guidelines for the management of two chronic conditions

J. Grimshaw, M. Eccles, E. McColl, 2002 .

converting AQLQ into EQ5D indices

J. Brazier, A. Tsuchiya, D. Parkin, 2011 .

Comparing Health Service Efficiency Across Countries

D. Parkin, 1989 .

International comparisons of health expenditure.

D. Parkin, 1993, Journal of public health medicine.

Searching for cost effectiveness thresholds in the NHS.

M. Buxton, K. Chalkidou, N. Devlin, 2009, Health policy.

Rationale and design of the SMaRT trial: A randomised, prospective, parallel, non-blinded, one-centre trial to evaluate the use of magnetic resonance imaging in acute setting in patients presenting with suspected scaphoid fracture

V. Goh, P. McCrone, D. Parkin, 2018, Clinical trials.

The economic evidence for advanced imaging in the diagnosis of suspected scaphoid fractures: systematic review of evidence

V. Goh, P. McCrone, D. Parkin, 2018, The Journal of hand surgery, European volume.

EQ-5D-5L

G. Bonsel, C. Gudex, P. Kind, 2017 .

Chiropody and the QALY: a case study in assigning categories of disability and distress to patients.

S. Bryan, C. Donaldson, D. Parkin, 1991, Health policy.

Cost-effectiveness of outpatient versus inpatient non-invasive ventilation setup in obesity hypoventilation syndrome: the OPIP trial

A. Cuvelier, J. Muir, J. Pépin, 2022, Thorax.

Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life

D. Bates, A. Jacoby, P. McNamee, 2000, Journal of neurology, neurosurgery, and psychiatry.

Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England

N. Devlin, D. Parkin, K. Hernandez-Villafuerte, 2019 .

Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

David Parkin, Nancy Devlin, N. Devlin, 2004, Health economics.

Treatment of multiple sclerosis with interferon â : an appraisal of coste V ectiveness and quality of life

A. Jacoby, P. McNamee, D. Parkin, 2000 .

Estimating health system opportunity costs: the role of non-linearities and inefficiency

N. Devlin, B. Zamora, D. Parkin, 2022, Cost Effectiveness and Resource Allocation.

Funding fertility: Issues in the allocation and distribution of resources to assisted reproduction technologies

N. Devlin, D. Parkin, 2003, Human fertility.

Loss to follow-up after total hip replacement: a source of bias in patient reported outcome measures and registry datasets?

D. Parkin, R. Field, S. Barke, 2014, Hip international : the journal of clinical and experimental research on hip pathology and therapy.

Using health status to measure NHS performance: casting light in dark places

N. Devlin, D. Parkin, 2011, BMJ quality & safety.

Assessing the performance of the EQ-VAS in the NHS PROMs programme

David Parkin, Yan Feng, N. Devlin, 2012, Quality of Life Research.

The Effect of Perceived Risks on the Demand for Vaccination: Results from a Discrete Choice Experiment

W. Edmunds, N. Devlin, D. Parkin, 2013, PloS one.

A single European currency for EQ-5D health states

Aki Tsuchiya, Paul Kind, Siem Oppe, 2003, The European Journal of Health Economics, formerly: HEPAC.

Patient charges and the use of dental services: some evidence

D. Parkin, B. Yule, M. Ryan, 1988, British Dental Journal.

Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation

R. Thomson, M. Eccles, D. Parkin, 2000, The Lancet.

NICE's cost effectiveness threshold

David Parkin, John Appleby, N. Devlin, 2007, BMJ : British Medical Journal.

Inter-provider comparison of patient-reported outcomes: developing an adjustment to account for differences in patient case mix.

N. Devlin, D. Parkin, D. Nuttall, 2015, Health economics.

A comparison of the plasma disappearance of iohexol and 99mTc-DTPA for the measurement of glomerular filtration rate (GFR) in diabetes.

G. Jerums, T. Osicka, D. Parkin, 1999, Australian and New Zealand journal of medicine.

Patients' views of explicit rationing: what are the implications for health service decision-making?

N. Devlin, D. Parkin, J. Appleby, 2003, Journal of health services research & policy.

What do international comparisons of health care expenditures really show?

A. Mcguire, D. Parkin, B. Yule, 1989, Community medicine.

Is there a case for using visual analogue scale valuations in cost-utility analysis?

David Parkin, Nancy Devlin, N. Devlin, 2006, Health economics.

A cost-utility analysis of interferon beta for multiple sclerosis.

A. Jacoby, D. Parkin, S. Thomas, 1998, Health technology assessment.

Medium-term cost-effectiveness of an automated non-invasive ventilation outpatient set-up versus a standard fixed level non-invasive ventilation inpatient set-up in obese patients with chronic respiratory failure: a protocol description

A. Cuvelier, J. Pépin, M. Polkey, 2015, BMJ Open.

Economic Analysis in Health Care

David Parkin, Stephen Morris, Nancy Devlin, 2007 .

Aggregate health care expenditures and national income. Is health care a luxury good?

A. Mcguire, D. Parkin, A McGuire, 1987, Journal of health economics.

A review of the evidence for the impact of improving nutritional care on nutritional and clinical outcomes and cost.

K. Whelan, D. Parkin, P. Emery, 2009, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models

W. Edmunds, N. Devlin, D. Parkin, 2005 .

From the generic to the condition-specific?: Instrument order effects in Quality of Life Assessment.

Jeremy M. Grimshaw, David Parkin, Martin Eccles, 2003 .

Accounts from developers of generic health state utility instruments explain why they produce different QALYs: A qualitative study.

K. Pickles, C. Donaldson, E. Lancsar, 2019, Social science & medicine.

An Introduction to EQ-5D Instruments and Their Applications

David Parkin, Nancy Devlin, Bas Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

How patients with atrial fibrillation value different health outcomes: a standard gamble study.

M Eccles, R. Thomson, M. Eccles, 2001, Journal of health services research & policy.

Economics: the biggest fraud ever perpetrated on the world?

A. Maynard, D. Parkin, J. Appleby, 2013, The Lancet.

What Determines the Shape of an EQ-5D Index Distribution?

David Parkin, Yan Feng, Nancy Devlin, 2014, Medical decision making : an international journal of the Society for Medical Decision Making.

Models of commissioning health services in the British National Health Service: a literature review.

P. Miller, D. Parkin, D. Chappel, 1999, Journal of public health medicine.

Clearing the fog on the Tyne: programme budgeting in Newcastle and North Tyneside Health Authority.

N. Craig, D. Parkin, K. Gerard, 1995, Health Policy.

EQ-5D-3L and quality of life in total knee arthroplasty (TKA) patients: beyond the index scores

D. Parkin, David William Parkin, B. Do Rego, 2022, Journal of Patient-Reported Outcomes.

Long term cost effectiveness of botulinum toxin A and sacral neuromodulation for patients with refractory overactive bladder.

D. Parkin, A. Al-Kaisy, A. Sahai, 2015 .

From the Generic to the Condition‐specific? Instrument Order Effects in Quality of Life Assessment

J. Grimshaw, M. Eccles, E. McColl, 2003, Medical care.

Recognising diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. A response to Sculpher and Gafni.

David Parkin, Angela Robinson, D. Parkin, 2002, Health economics.

The demand for dental care: an assessment.

D. Parkin, B. Yule, 1985, Social science & medicine.

Truly inefficient or providing better quality of care? Analysing the relationship between risk-adjusted hospital costs and patients' health outcomes.

A. Street, N. Devlin, N. Gutacker, 2011, Health economics.

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study

M. Greuter, K. Vermeulen, E. Buskens, 2018, Oncotarget.

University of Groningen Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer Koleva-Kolarova,

Karin, M. Greuter, E. Buskens, 2018 .

Use of a visual analogue scale in a daily patient diary: modelling cross-sectional time-series data on health-related quality of life.

Nigel Rice, David Parkin, J. Doughty, 2004, Social science & medicine.

Treatment of multiple sclerosis with interferon β: an appraisal of cost-effectiveness and quality of life

D. Bates, A. Jacoby, D. Parkin, 2000 .

Less fog on the Tyne? Programme budgeting in Newcastle and North Tyneside.

P. Miller, N. Craig, D. Parkin, 1997, Health policy.

Lanterns in the jungle: is the NHS driven by the wrong kind of efficiency?

L. Donaldson, N. Craig, D. Parkin, 1994, Public health.

Variations in Patients’ Overall Assessment of Their Health Across and Within Disease Groups Using the EQ-5D Questionnaire: Protocol for a Longitudinal Study in the Swedish National Quality Registers

N. Devlin, D. Parkin, O. Rolfson, 2021, JMIR research protocols.

Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups.

N. Devlin, B. Zamora, A. Bateman, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Advanced Topics

D. Parkin, N. Devlin, Bas Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

Treatment of multiple sclerosis with interferon (cid:226) : an appraisal of cost-e V ectiveness and quality of life

A. Jacoby, D. Parkin, P. Miller, 2000 .

Estimating the costs of conflict and containment on adult acute inpatient psychiatric wards.

C. Flood, L. Bowers, D. Parkin, 2008, Nursing economic$.

Investigating hospital efficiency in the new NHS: the role of the translog cost function.

A Scott, D. Parkin, D Parkin, 1995, Health economics.

Guidance to users of EQ-5D value sets

Nancy Devlin, David Parkin, N. Devlin, 2007 .

Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden

A. Abbott, M. Forssblad, D. Parkin, 2023, Health and Quality of Life Outcomes.

Analysis of EQ-5D Profiles

David Parkin, Nancy Devlin, Bas Janssen, 2020, Methods for Analysing and Reporting EQ-5D Data.

The Influence of Cost-Effectiveness and Other Factors on NICE Decisions

N. Devlin, N. Rice, D. Parkin, 2013, Health economics.

Econometric analyses of national health expenditures: can positive economics help to answer normative questions?

A. Mcguire, D. Parkin, D. Hughes, 1993, Health economics.

Exclusive human milk diet for very preterm babies in England: protocol for a cost-effectiveness and budget impact analysis

D. Parkin, G. Hampson, C. Sampson, 2021 .

THE DISTRIBUTION OF THE EQ-5D-5L INDEX IN PATIENTS POPULATIONS

David Parkin, Nancy Devlin, Yan Feng, 2016 .

Efficiency and productivity change in the English National Health Service: can data envelopment analysis provide a robust and useful measure?

David Parkin, Bruce Hollingsworth, B. Hollingsworth, 2003, Journal of health services research & policy.

Using EQ-5D Data to Measure Hospital Performance: Are General Population Values Distorting Patients’ Choices?

D. Parkin, K. Shah, T. Patton, 2020, Medical decision making : an international journal of the Society for Medical Decision Making.